<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Inflammatory reactions occurring in the brain after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> may contribute to secondary damage </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, effects of <z:chebi fb="1" ids="50694">minocycline</z:chebi>, an <z:chebi fb="1" ids="35472">anti-inflammatory agent</z:chebi>, alone or in combination with mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on focal embolic <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> have been examined </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Focal ischemic injury was induced by embolizing a preformed clot into the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>Infarction volume was measured at 48 h after the injury </plain></SENT>
<SENT sid="4" pm="."><plain>Mortality was also recorded </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Delayed administration of <z:chebi fb="1" ids="50694">minocycline</z:chebi> alone or delayed <z:chebi fb="1" ids="50694">minocycline</z:chebi> plus delayed mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> reduced the infarction volume significantly </plain></SENT>
<SENT sid="6" pm="."><plain>However, delayed mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> alone was not protective and delayed mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> in combination with <z:chebi fb="1" ids="50694">minocycline</z:chebi> did not show any additive effect </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results suggest that <z:chebi fb="1" ids="50694">minocycline</z:chebi> is beneficial in focal ischemic brain injury, and the lack of the enhanced neuroprotection may be due to the brief exposure to <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
</text></document>